Speed, Safety, and Industry Funding — From PDUFA I to PDUFA VI
Speed, Safety, and Industry Funding — From PDUFA I to PDUFA VI
About this item
Full title
Speed, Safety, and Industry Funding — From PDUFA I to PDUFA VI
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2017-12, Vol.377 (23), p.2278-2286
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The FDA Reauthorization Act of 2017 includes the sixth version of the Prescription Drug User Fee Act. User fees have accelerated drug approvals in the context of inadequate funding of the FDA, and industry now pays 75% of the costs of the scientific review of drugs.
Alternative Titles
Full title
Speed, Safety, and Industry Funding — From PDUFA I to PDUFA VI
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1974011818
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1974011818
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMhle1710706
